HCW Biologics Inc.

NASDAQ:HCWB

7.4 (USD) • At close April 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -30.024-24.994-14.901-12.862-5.802-7.293
Depreciation & Amortization 1.1841.1350.7180.5440.5960.422
Deferred Income Tax 000-0.501-4.319-0.079
Stock Based Compensation 1.0091.0041.120.3610.0220.002
Change In Working Capital 13.603-4.6432.4881.455-5.2470.104
Accounts Receivables 0.954-1.118-0.2852.367-2.50
Inventory 000000
Accounts Payables 11.8751.6190.4181.888-0.6290.766
Other Working Capital 0.775-5.1442.355-2.799-2.118-0.662
Other Non Cash Items -04.9840.1880.0284.3190.079
Operating Cash Flow -14.227-22.514-10.386-10.976-10.431-6.765
Investing Activities:
Investments In Property Plant And Equipment -0.262-6.203-10.275-0.047-0.187-1.46
Acquisitions Net 000000
Purchases Of Investments 000-34.97200
Sales Maturities Of Investments 01024.984000
Other Investing Activites 0024.984-34.97200
Investing Cash Flow -0.2623.79714.708-35.019-0.187-1.46
Financing Activities:
Debt Repayment 6.786-0.0386.44800.5640
Common Stock Issued 6.4630.0240.01656.030.010.06
Common Stock Repurchased 000000
Dividends Paid 000-2.82200
Other Financing Activities 2.320-0.191-6.7622.29926.833
Financing Cash Flow 15.569-0.0156.27349.26911.71813.447
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 1.079-18.73110.5963.2751.15.221
Cash At End Of Period 4.6753.59522.32611.7318.4567.356